Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia
Peter J. Weiden(Wilmington University), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Lauren Strand(Alkermes (United States)), James A McGrory(Alkermes (United States)), Eric D. Achtyes(Pine Rest Christian Mental Health Services), Jeffrey P. Trotter(Worldwide Clinical Trials (United States)), Christina Arevalo(Alkermes (United States)), Stephen R. Saklad, John M. Kane(University of North Carolina at Chapel Hill), Philip D. Harvey(University of Miami), Michael J. Doane(Alkermes (United States))
Cited by 1
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
|American Journal of Psychiatry|2015|849
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832